$6.53
0.152.35%
At close: -
$6.38
0.000.00%
Comments
Loading...
Latest DiaMedica Therapeutics Stock News | NASDAQ:DMAC | Benzinga
Get the latest news on DiaMedica Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on DiaMedica Therapeutics performance
Categories: All
Thursday, February 20, 2025
Tuesday, December 03, 2024
Friday, November 15, 2024
Wednesday, November 13, 2024
Tuesday, November 12, 2024
Thursday, October 10, 2024
Wednesday, October 09, 2024
Monday, October 07, 2024
Friday, August 16, 2024
Wednesday, August 07, 2024
Thursday, July 11, 2024
Wednesday, July 10, 2024
Wednesday, June 26, 2024
Wednesday, May 08, 2024
Wednesday, April 24, 2024
Wednesday, April 17, 2024
Thursday, March 21, 2024
Tuesday, March 19, 2024
Monday, November 13, 2023
Friday, November 10, 2023
Monday, August 14, 2023
Thursday, June 22, 2023
Wednesday, June 21, 2023
- DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199
- DiaMedica Therapeutics Announces $37.5M Private Placement Of 11,011,406 Common Shares At A Purchase Price Of $3.40/Share
- DiaMedica Therapeutics Announces That The FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke